Prospective Grant of an Exclusive Patent License: Manufacture, Distribution, Sale and Use of T-Cell-Based Immunotherapies for Solid Tumors

Summary

The Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Cancer Institute are contemplating the grant of an Exclusive Patent License to EnZeta Immunotherapies, Inc. for T-Cell-Based Immunotherapies for Solid Tumors.